CC
COLL icon

Centiva Capital’s Collegium Pharmaceutical COLL Stock Holding History

Centiva Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,289
Closed -$334K – 1242
2025
Q2 		$334K Buy
+11,289
New +$322K 0.02% 1153
2025
Q1 		– Sell
-10,727
Closed -$307K – 1633
2024
Q4 		$307K Buy
+10,727
New +$355K 0.01% 1119
2024
Q3 		– Sell
-24,568
Closed -$791K – 2221
2024
Q2 		$791K Buy
24,568
+13,100
+114% +$454K 0.04% 900
2024
Q1 		$445K Buy
11,468
+4,559
+66% +$160K 0.03% 1043
2023
Q4 		$213K Buy
+6,909
New +$173K 0.01% 1395

Other funds holding COLL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return